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Background: Endovascular revascularization has recently been established as a less invasive treatment method for
chronic mesenteric ischemia. However, intestinal necrosis caused by distal embolization following this procedure
has not been emphasized.
Case presentation: The present report describes a 59-year-old man who was treated with endovascular
revascularization for chronic mesenteric ischemia. After the procedure, he was diagnosed with intestinal necrosis
caused by distal embolization. Despite emergent bowel resection, he died on postoperative day 109.
Conclusion: Although endovascular revascularization for chronic mesenteric ischemia is less invasive and may be
suitable for high-risk patients, attention should be paid to avoid embolic complications that can cause intestinal
infarction possibly leading to a fatal condition.
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Endovascular revascularization (ER) is an emerging treat-
ment alternative for chronic mesenteric ischemia (CMI) [1].
Although open surgical revascularization (OR) yields a satis-
factory outcome with respect to symptom relief and primary
patency, it can be associated with perioperative morbidity
and mortality. ER is advantageous in that it is less invasive
[2,3]. However, procedure-related complications following
ER occur in approximately 10% of cases. Of these complica-
tions, distal embolization and subsequent bowel necrosis can
lead to a fatal condition [4-8]. The present report describes a
case of CMI associated with intestinal infarction after ER and
discusses the procedure-specific complications.Case presentation
A 59-year-old man with postprandial abdominal pain, diar-
rhoea, and vomiting was referred to our hospital. His body* Correspondence: tmiyata-tky@umin.ac.jp
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reproduction in any medium, provided the ormass index was 18.4. His symptoms improved with total
parenteral nutrition but relapsed after he resumed his nor-
mal diet. He had a history of multiple abdominal surgical
interventions. During the past 20 years, he had undergone
open drainage for acute pancreatitis, cholecystectomy and
choledochotomy for acute cholangitis, cystogastrostomy
for pancreatic pseudocyst, and choledocho-jejunostomy for
bile duct stenosis. He had a history of hypertension, dia-
betes, and cervical spondylosis, as well as a history of
smoking. An upper gastrointestinal endoscopy showed no
ischemic change, whereas total colonoscopy revealed ische-
mia in the distal ileum and the ascending colon. Enhanced
abdominal computed tomography (CT) showed stenosis of
the superior mesenteric artery (SMA) and occlusion of the
celiac and inferior mesenteric arteries with developed col-
lateral vessels from the SMA and left iliac artery (Figure 1).
The patient was diagnosed with CMI caused by splanch-
nic arterial stenoses and occlusions, and revascularization
of the SMA was necessary. We chose ER for this treat-
ment, taking into consideration his poor nutritional condi-
tion and hostile abdomen. The root of the SMA wasLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Computed tomography before the intervention. The
arrow indicates occlusion of the superior mesenteric artery. The
arrowheads indicate obstruction of the celiac and inferior mesenteric
arteries. The asterisk shows the development of a collateral vessel
from the left iliac artery.
a b
Figure 2 Digital subtraction angiography during percutaneous
transluminal angioplasty and stenting. (a) Stenosis was confirmed
near the root of the superior mesenteric artery (arrow). (b) After
dilatation, a stent (6 mm× 16 mm) was inserted (arrowhead).
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stenting to be appropriate. The procedure was performed
under local anaesthesia via the left brachial route. The
stenosis close to the origin of the SMA was traversed with
a 0.014-inch guidewire. After systemic administration of
3000 units of unfractionated heparin, the lesion was
predilated, and a stent (Palmaz Genesis, 6 mm× 16 mm,
Cordis/Johnson & Johnson, Miami, FL, USA) was placed
without apparent difficulty (Figure 2). He subsequently
received a continuous infusion of 15000 units of
unfractionated heparin for the first 24 hours and 100 mg
of aspirin per day.
The patient complained of right upper quadrant abdom-
inal pain after the intervention, and his white blood cell
count was elevated to 20 200/μL on the next day. Muscu-
lar guarding was present with further elevation of white
blood cell count on the second day, and CT revealed small
bowel necrosis with intestinal pneumatosis and bloody as-
cites. Emergency laparotomy was performed, and the nec-
rotic ileum and ischemic ascending colon were totally
resected. Post operatively, the patient suffered an ischemic
heart attack and liver abscess, which were both treated
nonsurgically. Although an ileostomy and a mucous fistula
of the colon were viable without ischemia throughout thepostoperative course, bacterial translocation from the in-
testine, which had already been damaged by chronic ische-
mia before ER, was suspected as a cause of the liver
abscess. He died of massive gastrointestinal bleeding on
postoperative day 109.
Discussion
Abdominal angina or CMI is characterized by postprandial
abdominal pain and weight loss. Insufficient intestinal
blood flow causes these symptoms and is usually produced
by the obstruction of 2 or 3 splanchnic vessels [7]. The
underlying etiology of this disease is atherosclerosis in more
than 90% of cases. Other causes include fibromuscular dys-
plasia, vasculitis (such as Takayasu arteritis, giant cell arter-
itis, polyarteritis nodosa, systemic lupus erythematosus, and
thromboangiitis obliterans), malignancy, and radiation.
Patients are initially treated with conservative therapy in-
cluding bowel resting, smoking cessation, and administra-
tion of vasodilator drugs. Revascularization is considered if
these conservative treatments fail to relieve the symptoms.
Open surgery has been the standard method for revascular-
ization in CMI. On the other hand, since the first report by
Furrer et al. on the effectiveness of percutaneous translumi-
nal angioplasty for CMI [2], ER has been considered as the
treatment of choice in some cases [9]. Previous studies have
reported the equivalent technical success and symptom re-
lief rates, and lower morbidity in ER, compared with OR.
Additionally, the primary patency rate is lower in ER than
in OR, resulting in more secondary interventions [2,3].
Therefore, ER is currently recommended for high-risk pa-
tients [8]. The therapeutic method for CMI should be
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often affected by systemic cardiovascular comorbidities, as
in our patient.
Patients treated with ER can have associated procedure-
specific complications, and sometimes follow catastrophic
courses, as in the present case. Distal embolization and ar-
terial dissection are often critical conditions. Eight cases of
distal embolization as a complication of ER for CMI have
been previously reported [4-8]. All of these patients under-
went bowel resection, and 7 of 8 patients died of postoper-
ative multiple organ failure (Table 1). Bowel necrosis and
subsequent sepsis can easily deteriorate the general condi-
tion of patients considered high risk for OR, causing 60%
of all deaths after ER for CMI [4-8]. Therefore, efforts
should be made to prevent embolization.
Little is known about the impact of stent placement in
terms of distal embolization. We did not use an embolic
protection device (EPD), because there is little evidence
showing its efficacy during ER for CMI. An EPD may be
useful in some cases with CMI [10,11]. Brown et al. [11]
reported the feasibility of routine EPD use because there
was no major perioperative morbidity in their endovascular
treatment. In percutaneous revascularization and stent
placement for renal artery stenosis, several reports have
suggested the efficacy of EPDs [12,13]. These studies
showed that embolic particles were observed in 60–90% of
cases treated for atherosclerotic renal arteries. However,
EPD use involves the intrinsic complications of vaso-
spasm, arterial dissection, arterial wall damage, distal
hypoperfusion, and even distal embolization [14,15]. Fur-
ther studies are necessary to verify the usefulness of EPDs
in cases with CMI.
Conclusion
Although ER for CMI is less invasive and may be suit-
able for high-risk patients, attention should be paid to
avoid embolic complications.
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